First Analysis — 2015 Investments

2 investments dated 2015 · listed companies and verified rows first · show all

Checkpoint Surgicalcheckpointsurgical.com inNov 2015

Checkpoint Surgical develops intraoperative nerve stimulation devices, biomaterial implants, and surgical instruments for peripheral nerve and tendon surgery.

BiotechHealthtechMedical DevicesCleveland, US

Marilyn A. Eisele(Executive Officer)Kevin M. Scanlan(Executive Officer)Donald Hubbard(Executive Officer)inMark Stultz(Executive Officer)

BoardGeoffrey B. Thrope(Executive Officer, Director)in

Board seatTracy Marshbanks· per SEC Form D

Co-investorsJumpstart Ventures Mutual Capital Partners NDI RC Capital

Csa Medical Increjuvenair.com inApr 2015

RejuvenAir, developed by CSA Medical, is a bronchoscopic cryosurgical device that sprays metered doses of liquid nitrogen to destroy damaged airway cells and treat the underlying cause of COPD with Chronic Bronchitis.

HealthtechMedical DevicesLutherville, US

Ellen Sheets(Executive Officer, Director)inIan J. Vawter(Executive Officer)Steven Schaefer(Executive Officer)inWilliam Floyd(Executive Officer, Director)inVincent Owens(Director)Richard Kent(Director)

Board seatTracy Marshbanks· per SEC Form D

Co-investorsAscension Ventures New Markets Venture Partners SV Health Investors Blue Heron Capital TVM Capital TVM Capital Life Science

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.